Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
The way the Nipah virus hit Kerala without warning, and the intensive efforts made by the state health authorities to contain its spread, has lessons for other states.
Medical investigators will need to overcome the rural region’s extreme logistical hurdles to reconstruct transmission chains, vaccinate contacts and halt the spread.
Although Congo may sorely lack infrastructure, it has one of the most successful Ebola response mechanisms in the world, according to researchers and aid workers.
The vaccine being deployed as a countermeasure to the current Ebola outbreak has been through efficacy trials in humans and showed 100 percent efficacy protecting against Ebola, but it has not been licensed.
National Institutes of Health (NIH) officials assured lawmakers on Thursday, May 17, that US health experts are following concerns of an Ebola outbreak in Africa closely, and said that medical countermeasures have already been deployed in response.
The 4,000 doses will be sent to the remote northwest where two confirmed Ebola cases, 20 probable ones and 20 suspected ones have been reported; while an additional 4,000 doses will be deployed in the coming days with more available if needed.
A new collaborative study has identified and studied Ebola antibodies that could be used to design universal therapeutics that are effective against many different Ebola species.
Mosquito nets infused with two pesticides work much better against malaria than those with only one, reducing prevalence in children by 44 percent.
The flow of seasonal migrant workers once made Richard Toll a malaria hot spot in Senegal, but a partnership between government and a private company has had remarkable results fighting the disease.